Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain.
about
The CRMP family of proteins and their role in Sema3A signalingGlycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsThe Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeletonThe multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foesAPP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammationTau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in MiceProteolytic processing of Alzheimer's β-amyloid precursor proteinThe Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's DiseaseTransgenic expression of the amyloid-beta precursor protein-intracellular domain does not induce Alzheimer's Disease-like traits in vivoPresenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expressionRole of X11 and ubiquilin as in vivo regulators of the amyloid precursor protein in DrosophilaAbnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain.GSK3beta: role in therapeutic landscape and development of modulators.Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease.Comparative transcriptome profiling of amyloid precursor protein family members in the adult cortexIdentification and characterization of a neuronal enriched novel transcript encoding the previously described p60Fe65 isoform.Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a Drosophila Alzheimer's disease model.Model Hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain.The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus.Epigenetic control of learning and memory in Drosophila by Tip60 HAT action.Epigenetic induction of EGR-1 expression by the amyloid precursor protein during exposure to novelty.Epigenetic regulations of immediate early genes expression involved in memory formation by the amyloid precursor protein of Alzheimer diseaseManipulations of amyloid precursor protein cleavage disrupt the circadian clock in aging Drosophila.The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD)Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.GSK3β Interactions with Amyloid Genes: An Autopsy Verification and ExtensionOxidative stress-dependent phosphorylation activates ZNRF1 to induce neuronal/axonal degenerationAppoptosin is a novel pro-apoptotic protein and mediates cell death in neurodegeneration.APP Receptor? To Be or Not To Be.Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional roleReassessing the amyloid cascade hypothesis of Alzheimer's diseaseInvolvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains.Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain.Interactions between GSK3β and amyloid genes explain variance in amyloid burden.Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's DiseasePharmacological targeting of the β-amyloid precursor protein intracellular domain.Amyloid-independent mechanisms in Alzheimer's disease pathogenesis
P2860
Q24597299-A7AFFF85-CB39-4F9E-9544-EE9CEEE08C87Q24685475-F9068C22-91C0-4E85-A28B-A83E69D3F415Q26864818-3B51E58C-CF20-4D7D-8295-39AF5D179FD8Q27026919-0FBA3C4B-6D8C-4EED-8F24-31BBFD80CDBBQ27322677-0C6EDE35-7DF1-4662-AC3B-48897ECEE662Q27334314-5B919FBE-FC00-42CD-8508-62F694EA0193Q28254104-CCE0A78B-BB4F-4F4C-910F-0B3B0F78306DQ28254943-FFA35DD9-F2A0-4462-A9C7-E5F30E67E4A1Q28474855-2ADEA88E-0094-49C1-9B9A-CC13622500E5Q28585864-4FCFEF1B-084E-4219-B8F3-4AA7C84399D7Q33346273-7F202E81-DCD6-4800-95D9-5D7C32955F38Q33510497-4BA1E256-FBBC-48A2-89CC-3EC7322DDE78Q33812730-9B522391-AC93-40D9-800C-96D838A63ABDQ33835175-7D2B8E5C-EA5D-4F05-BDA4-2F5AA7D5C399Q33854917-29E57ED1-3F9F-43A3-9127-629E8600F733Q33985290-4183A466-B493-41EA-B558-336D58CD17B8Q34359000-B9029933-5CE6-4FB1-A713-623914266EDDQ34427848-B51D60B0-0AA6-4532-9278-A432A54C99F2Q34477111-4D017071-A70F-43BF-9324-FED75C491052Q34636247-FF9188E2-6FDA-4B2E-A000-5A1C7183BDFBQ34997321-DF699797-0D94-49B4-8832-810C820BCA8BQ35185570-962512A9-C68B-4F05-B637-527B13935BC3Q35472679-D45455A2-BA2D-4BAF-A151-48D282ABC9DFQ35534062-0BC8458C-E7D4-460F-A64D-58AF7B510456Q35545259-38A6BA19-FC96-4830-83C1-A9092BBEC800Q36012200-3CD6E7A6-94AD-41C2-88A9-6AB9AB56692FQ36092947-823380E5-7472-4900-B918-639D36BC59B0Q36224340-16676BC0-CCC9-4659-894B-A659DD39841DQ36310572-29E81B76-624E-4E8E-9B66-F394703698E7Q36432966-B98DE46E-590E-47F1-9D17-82E842CD5E2BQ36840033-9393C41C-FC85-4C0F-8A4B-D804CEC7CF22Q36882015-EF32F854-EC7A-463F-9A18-74596E9C8D87Q37187966-9C343192-660F-47F5-B387-15533B9891C3Q37257096-49C9CCDC-D9AB-45B1-A763-A946875C30B0Q37295364-D1812776-F1C2-4128-A406-1B84B624110AQ37389332-0D206089-0325-4A66-9F71-6B8D17DA84F2Q37395893-C492C1E1-EDF2-458B-9BD1-AC2459BC58BCQ37408544-703F54A1-FED4-4DED-90BE-E54D415B37C0Q37693126-DA213001-A8BD-4D43-AFC1-0028EAB856A1Q37808579-449F4FC5-BC47-4F74-9CA6-BCA53948801C
P2860
Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Activation of GSK-3 and phosph ...... sing APP intracellular domain.
@ast
Activation of GSK-3 and phosph ...... sing APP intracellular domain.
@en
type
label
Activation of GSK-3 and phosph ...... sing APP intracellular domain.
@ast
Activation of GSK-3 and phosph ...... sing APP intracellular domain.
@en
prefLabel
Activation of GSK-3 and phosph ...... sing APP intracellular domain.
@ast
Activation of GSK-3 and phosph ...... sing APP intracellular domain.
@en
P2860
P356
P1476
Activation of GSK-3 and phosph ...... sing APP intracellular domain.
@en
P2093
Kathleen A Ryan
Sanjay W Pimplikar
P2860
P304
P356
10.1083/JCB.200505078
P407
P577
2005-10-17T00:00:00Z